The Sam Schneider Legacy
In support of Sam’s vision, we have created The Sam Schneider Legacy. Our mission is to raise funds for Ewing sarcoma research, raise awareness of pediatric cancer, and tell Sam's story.
Sam's Story

To date, we have raised over $290,000 for lifesaving childhood cancer research.
Funds raised by the Sam Schneider Legacy support CureSearch 2023-2025 Acceleration Initiative awardee John Lee, MD, PhD, at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Lee is working on a new targeted immune-based treatment for advanced Ewing sarcoma.
